一种与产前芬太尼暴露相关的新型综合征
Erin Wadman1, Erica Fernandes1, Candace Muss1
1Division of Medical Genetics, Nemours Children's Hospital, Wilmington, DE.
Genetics in medicine open
|December 13, 2024
概括
一种由发育问题和出生缺陷为特征的新型综合征与产前芬太尼暴露有关. 这种情况类似于史密斯-莱姆利-奥皮茨综合征,并表明芬太尼可能是原体.
科学领域:
- 医学遗传学 医学遗传学
- 甲状腺学 甲状腺学
- 发展生物学 发展生物学
背景情况:
- 怀疑是一种新型综合征,具有矮身,小头,独特的面部特征和先天异常.
- 现有的病例表现出与史密斯-莱姆利-奥皮茨综合征重叠的特征,促使进一步调查.
研究的目的:
- 描述在婴儿中观察到的一种新型综合征,婴儿在产前暴露于非处方阿片类药物.
- 调查芬太尼对胎儿发育的潜在原性影响.
主要方法:
- 评估了10名受影响个体的病史,身体发现,面部照片和测试结果.
- 生物化学研究以评估胆固醇代谢异常.
- 对产前暴露的怀孕史的分析.
主要成果:
- 十个病例呈现了小头症,矮身,独特的面部特征和先天性形 (例如,口腔裂,尾巴 equinovarus).
- 生物化学研究揭示了胆固醇代谢中的短暂异常.
- 所有受影响的婴儿都在产前接触过非处方阿片类药物,特别是芬太尼.
结论:
- 一种与产前芬太尼暴露相关的新型综合征在临床上是可识别的.
- 芬太尼被认为是一种潜在的原体,可能会干扰胆固醇代谢.
- 需要进一步的研究和数据复制来确认因果关系.
关键词:
胚胎疗法是一种胚胎疗法.格斯塔尔特匹配器 (英语:GestaltMatcher) 是一款使用格斯塔尔特匹配器的工具.片类药物使用障碍.产前暴露于芬太尼的情况.史密斯-莱姆利-奥皮茨综合征是什么?更多相关视频
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Genomic Imprinting and Inheritance
33.3K
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
33.3K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
223
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
223


